About: Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia. It develops DMX-200 for the treatment of focal segmental glomerulosclerosis disease; as well as DMX-652 for the treatment of acute kidney injury. The company is headquartered in Fitzroy, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.23 (+2.27%)
DXB ASX Dimerix Ltd
Loading watchlist status…
Dimerix Ltd share price
DXB price activity
Last Price
$0.230
Change (24hr)
0.01 AUD (2.27%)
Volume
278.90K
Volume (4w avg)
-
Open
$0.23
Day Range
$0.22 - $0.23
Previous Close
$0.22
Last Trade
09 Oct, 4:56 am GMT+0
Delayed
09 Oct, 4:56 am GMT+0
DXB price performance
0%
5D
-16.67%
1M
-59.09%
YTD
-60.18%
1Y
Delayed
09 Oct, 4:56 am GMT+0
DXB Market Signals